Ali, S. A., Valeri, L., Kahe, K., Genkinger, J. M., Saleem, S., Jessani, S., Goldenberg, R. L., Westcott, J. E., Kemp, J. F., Garcés, A. L., Figueroa, L., Goudar, S. S., Dhaded, S. M., Derman, R. J., Tshefu, A., Lokangaka, A. L., Bauserman, M. S., McClure, E. M., Koso Thomas, M., … Hendricks, A. E. (2025). Hemoglobin During Pregnancy Does Not Mediate the Relationship between Nutrition Supplements and Intrauterine Growth: A Secondary Data Analysis of Women First Preconception Nutrition Trial. The Journal of Nutrition. https://doi.org/10.1016/j.tjnut.2025.04.036

Naggayi, S. K., Kalibbala, D., Mboizi, V., Ssenkusu, J. M., Jin, Z., Rosano, C., Munube, D., Wambaka, B., Namazzi, R., Kasirye, P. G., Kabatabaazi, M., Nambatya, G., Murungi, S., Nabaggala, C., Nakafeero, M. R., Troidl, I. R., Opoka, R. O., Idro, R., Bangirana, P., & Green, N. S. (2025). Neurocognitive Gains Among Ugandan Children with Sickle Cell Anemia on Hydroxyurea: 18-month trial interim results. Blood Advances. https://doi.org/10.1182/bloodadvances.2024015073

Mboizi, V., Nabaggala, C., Munube, D., Ssenkusu, J. M., Kasirye, P., Kamya, S., Kawooya, M. G., Boehme, A., Minja, F., Mupere, E., Opoka, R., Rosano, C., Idro, R., & Green, N. S. (2024). Hydroxyurea therapy for neurological and cognitive protection in pediatric sickle cell anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial. Contemporary Clinical Trials Communications, 42, 101404. https://doi.org/10.1016/j.conctc.2024.101404

Reisz, J. A., Earley, E. J., Nemkov, T., Key, A., Stephenson, D., Keele, G. R., Dzieciatkowska, M., Spitalnik, S. L., Hod, E. A., Kleinman, S., Roubinian, N. H., Gladwin, M. T., Hansen, K. C., Norris, P. J., Busch, M. P., Zimring, J. C., Churchill, G. A., Page, G. P., & D’Alessandro, A. (2024). Arginine metabolism is a biomarker of red blood cell and human aging. Aging Cell. Portico. https://doi.org/10.1111/acel.14388

Metta, E. O., Muhihi, A., Paulo, H. A., Sudfeld, C. R., Kaale, A., Perumal, N., Mwanyika‐Sando, M., Swai, N. O., Duggan, C. P., Masanja, H., Wylie, B. J., Pembe, A. B., & Fawzi, W. (2024). Experiences, acceptability and barriers to calcium supplementation during pregnancy in Dar es Salaam, Tanzania. Maternal & Child Nutrition. Portico. https://doi.org/10.1111/mcn.13732

Bangirana, P., Boehme, A. K., Birabwa, A., Opoka, R. O., Munube, D., Mupere, E., Kasirye, P., Muwanguzi, G., Musiimenta, M., Ru, G., Green, N. S., & Idro, R. (2024). Neurocognitive impairment in Ugandan children with sickle cell anemia compared to sibling controls: a cross-sectional study. Frontiers in Stroke, 3. https://doi.org/10.3389/fstro.2024.1372949

Naggayi, S. K., Kalibala, D., Opoka, R., Rosano, C., Munube, D., Kasirye, P., Mupere, E., Mboizi, V., Ssenkusu, J., Green, N. S., Idro, R., & Bangirana, P. (2023). Neurocognitive Improvement with Hydroxyurea Therapy in Children with Sickle Cell Anemia in Uganda: Interim Analysis at Month 18. Blood, 142(Supplement 1), 275–275. https://doi.org/10.1182/blood-2023-190687

Kalibala, D., Nabaggala, C., Turyagyenda, L., Mboizi, V., Naggayi, S. K., Kabatabaazi, M., Rosano, C., Munube, D., Kasirye, P., Ssenkusu, J., Opoka, R., Bangirana, P., Green, N. S., Idro, R., & Mupere, E. (2023). Effect of Hydroxyurea Treatment on Body Composition in Children with Sickle Cell Anemia in Uganda Using Bioelectrical Impedance Analysis (BIA). Blood, 142(Supplement 1), 1136–1136. https://doi.org/10.1182/blood-2023-190181

Namazzi, R., Idro, R., Kalibala, D., Ssenkusu, J., Akun, P., Mboizi, V., Gondwe, T. N., Munube, D., Kasirye, P., Nabaggala, C., John, C. C., Green, N. S., Robberstat, B., Hensbroek, B. van, Kuile, F. ter, Phiri, K. S., & Opoka, R. (2023). Malaria in Children with Sickle Cell Anaemia in Areas with Low, Moderate and High Transmission in Uganda. Blood, 142(Supplement 1), 5327–5327. https://doi.org/10.1182/blood-2023-189066

Green, N. S., Manwani, D., Aygun, B., Appiah-Kubi, A., Smith-Whitley, K., Jia, H., & Smaldone, A. (2023). Habit Efficacy Trial: A Multi-Site Randomized Controlled Trial of Community Health Worker Support to Increase Hydroxyurea Adherence of Youth with Sickle Cell Disease. Blood, 142(Supplement 1), 3901–3901. https://doi.org/10.1182/blood-2023-190031

Green, N. S., Rosano, C., Bangirana, P., Opoka, R., Munube, D., Kasirye, P., Kawooya, M., Lubowa, S. K., Mupere, E., Conroy, A., Minja, F. J., Boehme, A. K., Kang, M. S., Honig, L. S., & Idro, R. (2023). Neurofilament light chain: A potential biomarker for cerebrovascular disease in children with sickle cell anaemia. British Journal of Haematology, 203(3), 460–467. Portico. https://doi.org/10.1111/bjh.19036

De, A., Williams, S., Yao, Y., Jin, Z., Brittenham, G. M., Kattan, M., Lovinsky-Desir, S., & Lee, M. T. (2023). Acute chest syndrome, airway inflammation and lung function in sickle cell disease. PLOS ONE, 18(3), e0283349. https://doi.org/10.1371/journal.pone.0283349

Reeves, S. L., Peng, H. K., Wing, J. J., Cogan, L. W., Goel, A., Anders, D., Green, N. S., Lisabeth, L. D., & Dombkowski, K. J. (2023). Changes in Hydroxyurea Use Among Youths Enrolled in Medicaid With Sickle Cell Anemia After 2014 Revision of Clinical Guidelines. JAMA Network Open, 6(3), e234584. https://doi.org/10.1001/jamanetworkopen.2023.4584

Green, N. S., Zapfel, A., Nnodu, O. E., Franklin, P., Tubman, V. N., Chirande, L., Kiyaga, C., Chunda-Liyoka, C., Awuonda, B., Ohene-Frempong, K., Inusa, B. P. D., Ware, R. E., Odame, I., Ambrose, E. E., Dogara, L. G., Oron, A. P., Willett, C., Thompson, A. A., Berliner, N., … Novelli, E. M. (2022). The Consortium on Newborn Screening in Africa for sickle cell disease: study rationale and methodology. Blood Advances, 6(24), 6187–6197. https://doi.org/10.1182/bloodadvances.2022007698

Smaldone, A., Manwani, D., Aygun, B., Appiah-Kubi, A., Smith-Whitley, K., & Green, N. S. (2022). Assessing Multi-Level Barriers to Medication Adherence in Youth with Sickle Cell Disease Using Pharmacy-Based Prescription Refill Data. Blood, 140(Supplement 1), 2149–2150. https://doi.org/10.1182/blood-2022-157527

P., B., R., I., R., O., D., M., E., M., P., K., N., G., & A., B. (2022). O-08: NEUROCOGNITIVE IMPAIRMENT IN UGANDAN CHILDREN WITH SICKLE CELL ANEMIA COMPARED TO NON-SICKLE SIBLINGS. HemaSphere, 6, 05–06. https://doi.org/10.1097/01.hs9.0000872840.49305.3f

Kanter, J., Walters, M. C., Krishnamurti, L., Mapara, M. Y., Kwiatkowski, J. L., Rifkin-Zenenberg, S., Aygun, B., Kasow, K. A., Pierciey, F. J., Bonner, M., Miller, A., Zhang, X., Lynch, J., Kim, D., Ribeil, J.-A., Asmal, M., Goyal, S., Thompson, A. A., & Tisdale, J. F. (2022). Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease. New England Journal of Medicine, 386(7), 617–628. https://doi.org/10.1056/nejmoa2117175

La Carpia, F., Slate, A., Bandyopadhyay, S., Wojczyk, B. S., Godbey, E. A., Francis, K. P., Prestia, K., & Hod, E. A. (2021). Red blood cell transfusion‐induced non‐transferrin‐bound iron promotes Pseudomonas aeruginosa biofilms in human sera and mortality in catheterized mice. British Journal of Haematology, 196(4), 1105–1110. Portico. https://doi.org/10.1111/bjh.17934

Akpan, I. J., & Pavord, S. (2022). Gynecologic Conditions and Anemia: What Can We Do About Iron Deficiency Anemia in Women? The Hematologist, 19(3). https://doi.org/10.1182/hem.v19.3.2022311

Askew, M., Smaldone, A., Gold, M. A., Smith-Whitley, K., Strouse, J. J., Jin, Z., & Green, N. S. (2021). National Survey of Pediatric Sickle Cell Providers on Their Contraceptive Practices for Female Patients. Blood, 138(Supplement 1), 1898–1898. https://doi.org/10.1182/blood-2021-154083

Walters, M. C., Tisdale, J. F., Mapara, M. Y., Krishnamurti, L., Kwiatkowski, J. L., Aygun, B., Kasow, K. A., Rifkin-Zenenberg, S., Jaroscak, J., Garbinsky, D., Chirila, C., Gallagher, M. E., Zhang, X., Ho, P.-R., Thompson, A. A., & Kanter, J. (2021). Sustained Improvements in Patient-Reported Quality of Life up to 24 Months Post-Treatment with LentiGlobin for Sickle Cell Disease (bb1111) Gene Therapy. Blood, 138(Supplement 1), 7–7. https://doi.org/10.1182/blood-2021-146905